The role of neutrophil gelatinase associated lipocalin (NGAL) as biological constituent linking depression and cardiovascular disease

Brain, Behavior, and Immunity

Volumn 46, Issue , 2015, Pages 23-32

  Gouweleeuw, L ^a   Naude P J W ^a,b   Rots, M ^a   DeJongste, M J L ^b   Eisel, U L M ^a   Schoemaker, R G ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiovascular disease; Depression; Heart failure; Inflammation; Lcn 2; Neuroinflammation; NGAL

Indexed keywords

MEGALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN 24P3R; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; DEPRESSION; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; META ANALYSIS (TOPIC); NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; BLOOD; COMPLICATION; MAJOR DEPRESSION;

ACUTE-PHASE PROTEINS; BIOMARKERS; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER, MAJOR; HUMANS; INFLAMMATION; LIPOCALINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 84928825900     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.12.026     Document Type: Review

References (147)

1. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
2. Aigner F., Maier H.T., Schwelberger H.G., Wallnofer E.A., Amberger A., Obrist P., Berger T., Mak T.W., Maglione M., Margreiter R., Schneeberger S., Troppmair J. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am. J. Transplant. 2007, 7:779-788.
3. Andrei A.M., Fraguas R., Telles R.M., Alves T.C., Strunz C.M., Nussbacher A., Rays J., Iosifescu D.V., Wajngarten M. Major depressive disorder and inflammatory markers in elderly patients with heart failure. Psychosomatics 2007, 48:319-324.
4. Badoer E. Microglia: activation in acute and chronic inflammatory states and in response to cardiovascular dysfunction. Int. J. Biochem. Cell Biol. 2010, 42:1580-1585.
5. Barefoot J.C., Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996, 93:1976-1980.
6. Basaran Y., Basaran M.M., Babacan K.F., Ener B., Okay T., Gok H., Ozdemir M. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology 1993, 44:332-337.
7. Berard J.L., Zarruk J.G., Arbour N., Prat A., Yong V.W., Jacques F.H., Akira S., David S. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia 2012, 60:1145-1159.
8. Berger T., Togawa A., Duncan G.S., Elia A.J., You-Ten A., Wakeham A., Fong H.E., Cheung C.C., Mak T.W. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1834-1839.
9. Bi F., Huang C., Tong J., Qiu G., Huang B., Wu Q., Li F., Xu Z., Bowser R., Xia X.G., Zhou H. Reactive astrocytes secrete lcn2 to promote neuron death. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:4069-4074.
10. Blum A., Sclarovsky S., Rehavia E., Shohat B. Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am. Heart J. 1994, 127:1226-1230.
11. Borkham-Kamphorst E., Drews F., Weiskirchen R. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1beta through nuclear factor-kappa B activation. Liver Int. 2011, 31:656-665.
12. Borregaard N., Cowland J.B. Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals 2006, 19:211-215.
13. Bourdon K.H., Rae D.S., Locke B.Z., Narrow W.E., Regier D.A. Estimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area Survey. Public Health Rep. 1992, 107:663-668.
14. Brambilla F., Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr. Scand. 1998, 97:309-313.
15. Bush D.E., Ziegelstein R.C., Patel U.V., Thombs B.D., Ford D.E., Fauerbach J.A., McCann U.D., Stewart K.J., Tsilidis K.K., Patel A.L., Feuerstein C.J., Bass E.B. Post-myocardial infarction depression. Evid. Rep. Technol. Assess. (Summ) 2005, 123:1-8.
16. Carney R.M., Freedland K.E., Sheline Y.I., Weiss E.S. Depression and coronary heart disease: a review for cardiologists. Clin. Cardiol. 1997, 20:196-200.
17. Celano C.M., Huffman J.C. Depression and cardiac disease: a review. Cardiol. Rev. 2011, 19:130-142.
18. Charlson F.J., Moran A.E., Freedman G., Norman R.E., Stapelberg N.J., Baxter A.J., Vos T., Whiteford H.A. The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med. 2013, 11. 250-7015-11-250.
19. Connor T.J., Leonard B.E. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 1998, 62:583-606.
20. Cooper D.C., Trivedi R.B., Nelson K.M., Reiber G.E., Eugenio E.C., Beaver K.A., Fan V.S. Antidepressant adherence and risk of coronary artery disease hospitalizations in older and younger adults with depression. J. Am. Geriatr. Soc. 2014, 62:1238-1245.
21. Cowland J.B., Sorensen O.E., Sehested M., Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J. Immunol. 2003, 171:6630-6639.
22. Crichton R.R., Dexter D.T., Ward R.J. Brain iron metabolism and its perturbation in neurological diseases. J. Neural Transm. 2011, 118:301-314.
23. Damman K., van Veldhuisen D.J., Navis G., Voors A.A., Hillege H.L. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur. J. Heart Fail. 2008, 10:997-1000.
24. Daniels L.B., Barrett-Connor E., Clopton P., Laughlin G.A., Ix J.H., Maisel A.S. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J. Am. Coll. Cardiol. 2012, 59:1101-1109.
25. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
26. Dao T.K., Youssef N.A., Gopaldas R.R., Chu D., Bakaeen F., Wear E., Menefee D. Autonomic cardiovascular dysregulation as a potential mechanism underlying depression and coronary artery bypass grafting surgery outcomes. J. Cardiothorac. Surg. 2010, 5. 36-8090-5-36.
27. De Berardinis B., Gaggin H.K., Magrini L., Belcher A., Zancla B., Femia A., Simon M., Motiwala S., Bhardwaj A., Parry B.A., Nagurney J.T., Coudriou C., Legrand M., Sadoune M., Di Somma S., Januzzi J.L., From the Global Research on Acute Conditions Team (GREAT) Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure. Clin. Chem. Lab. Med. 2014.
28. de Miranda Azevedo R., Roest A.M., Hoen P.W., de Jonge P. Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis. Psychol. Med. 2014, 44:2689-2703.
29. Devireddy L.R., Gazin C., Zhu X., Green M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005, 123:1293-1305.
30. Di Grande A., Giuffrida C., Carpinteri G., Narbone G., Pirrone G., Di Mauro A., Calandra S., Noto P., Le Moli C., Alongi B., Nigro F. Neutrophil gelatinase-associated lipocalin: a novel biomarker for the early diagnosis of acute kidney injury in the emergency department. Eur. Rev. Med. Pharmacol. Sci. 2009, 13:197-200.
31. Dietrich M., Antequera D., Pascual C., Castro N., Bolos M., Carro E. Alzheimer's disease-like impaired cognition in endothelial-specific megalin-null mice. J. Alzheimers Dis. 2014, 39:711-717.
32. Ding L., Hanawa H., Ota Y., Hasegawa G., Hao K., Asami F., Watanabe R., Yoshida T., Toba K., Yoshida K., Ogura M., Kodama M., Aizawa Y. Lipocalin-2/neutrophil gelatinase-B associated lipocalin is strongly induced in hearts of rats with autoimmune myocarditis and in human myocarditis. Circ. J. 2010, 74:523-530.
33. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
34. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
35. Dworak M., Stebbing M., Kompa A.R., Rana I., Krum H., Badoer E. Sustained activation of microglia in the hypothalamic PVN following myocardial infarction. Auton. Neurosci. 2012, 169:70-76.
36. Ferketich A.K., Ferguson J.P., Binkley P.F. Depressive symptoms and inflammation among heart failure patients. Am. Heart J. 2005, 150:132-136.
37. Ferreira A.C., Pinto V., Da Mesquita S., Novais A., Sousa J.C., Correia-Neves M., Sousa N., Palha J.A., Marques F. Lipocalin-2 is involved in emotional behaviors and cognitive function. Front. Cell. Neurosci. 2013, 7:122.
38. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., Akira S., Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432:917-921.
39. Flower D.R. Beyond the superfamily: the lipocalin receptors. Biochim. Biophys. Acta. 2000, 1482:327-336.
40. Francis J., Chu Y., Johnson A.K., Weiss R.M., Felder R.B. Acute myocardial infarction induces hypothalamic cytokine synthesis. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H2264-71.
41. Frangogiannis N.G. The mechanistic basis of infarct healing. Antioxid. Redox Signal. 2006, 8:1907-1939.
42. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 2002, 53:31-47.
43. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993, 270:1819-1825.
44. Frey A., Popp S., Post A., Langer S., Lehmann M., Hofmann U., Siren A.L., Hommers L., Schmitt A., Strekalova T., Ertl G., Lesch K.P., Frantz S. Experimental heart failure causes depression-like behavior together with differential regulation of inflammatory and structural genes in the brain. Front. Behav. Neurosci. 2014, 8:376.
45. Garden G.A., Moller T. Microglia biology in health and disease. J. Neuroimmune Pharmacol. 2006, 1:127-137.
46. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell. 2002, 10:1033-1043.
47. Grippo A.J., Francis J., Weiss R.M., Felder R.B., Johnson A.K. Cytokine mediation of experimental heart failure-induced anhedonia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R666-73.
48. Gustad L.T., Laugsand L.E., Janszky I., Dalen H., Bjerkeset O. Symptoms of anxiety and depression and risk of heart failure: the HUNT study. Eur. J. Heart Fail. 2014, 16:861-870.
49. Hamzic N., Blomqvist A., Nilsberth C. Immune-induced expression of lipocalin-2 in brain endothelial cells: relationship with interleukin-6, cyclooxygenase-2 and the febrile response. J. Neuroendocrinol. 2013, 25:271-280.
50. Han M., Li Y., Liu M., Li Y., Cong B. Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat. BMC Nephrol. 2012, 13. 25-2369-13-25.
51. Hance M., Carney R.M., Freedland K.E., Skala J. Depression in patients with coronary heart disease. A 12-month follow-up. Gen. Hosp. Psychiatry 1996, 18:61-65.
52. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
53. Hemdahl A.L., Gabrielsen A., Zhu C., Eriksson P., Hedin U., Kastrup J., Thoren P., Hansson G.K. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2006, 26:136-142.
54. Hoen P.W., Whooley M.A., Martens E.J., Na B., van Melle J.P., de Jonge P. Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J. Am. Coll. Cardiol. 2010, 56:838-844.
55. Holzapfel N., Muller-Tasch T., Wild B., Junger J., Zugck C., Remppis A., Herzog W., Lowe B. Depression profile in patients with and without chronic heart failure. J. Affect. Disord. 2008, 105:53-62.
56. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
57. Hvidberg V., Jacobsen C., Strong R.K., Cowland J.B., Moestrup S.K., Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005, 579:773-777.
58. Ikeda U., Ohkawa F., Seino Y., Yamamoto K., Hidaka Y., Kasahara T., Kawai T., Shimada K. Serum interleukin 6 levels become elevated in acute myocardial infarction. J. Mol. Cell. Cardiol. 1992, 24:579-584.
59. Ip J.P., Nocon A.L., Hofer M.J., Lim S.L., Muller M., Campbell I.L. Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. J. Neuroinflammation 2011, 8. 124-2094-8-124.
60. Jang E., Lee S., Kim J.H., Kim J.H., Seo J.W., Lee W.H., Mori K., Nakao K., Suk K. Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J. 2013, 27:1176-1190.
61. Jha M.K., Jeon S., Jin M., Ock J., Kim J.H., Lee W.H., Suk K. The pivotal role played by lipocalin-2 in chronic inflammatory pain. Exp. Neurol. 2014, 254:41-53.
62. Johansson P., Lesman-Leegte I., Svensson E., Voors A., van Veldhuisen D.J., Jaarsma T. Depressive symptoms and inflammation in patients hospitalized for heart failure. Am. Heart J. 2011, 161:1053-1059.
63. Jones K.A., Thomsen C. The role of the innate immune system in psychiatric disorders. Mol. Cell. Neurosci. 2013, 53:52-62.
64. Kang Y.M., He R.L., Yang L.M., Qin D.N., Guggilam A., Elks C., Yan N., Guo Z., Francis J. Brain tumour necrosis factor-alpha modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovasc. Res. 2009, 83:737-746.
65. Kaster M.P., Gadotti V.M., Calixto J.B., Santos A.R., Rodrigues A.L. Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 2012, 62:419-426.
66. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S., National Comorbidity Survey Replication The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
67. Kim H., Lee S., Park H.C., Lee W.H., Lee M.S., Suk K. Modulation of glial and neuronal migration by lipocalin-2 in zebrafish. Immune Netw. 2011, 11:342-347.
68. Kjeldsen L., Bainton D.F., Sengelov H., Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994, 83:799-807.
69. Kjeldsen L., Cowland J.B., Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim. Biophys. Acta 2000, 1482:272-283.
70. Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 1993, 268:10425-10432.
71. Kop W.J., Stein P.K., Tracy R.P., Barzilay J.I., Schulz R., Gottdiener J.S. Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom. Med. 2010, 72:626-635.
72. Kupper N., Widdershoven J.W., Pedersen S.S. Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients. J. Affect. Disord. 2012, 136:567-576.
73. Kushner I., Broder M.L., Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J. Clin. Invest. 1978, 61:235-242.
74. Langelueddecke C., Roussa E., Fenton R.A., Wolff N.A., Lee W.K., Thevenod F. Lipocalin-2 (24p3/neutrophil gelatinase-associated lipocalin (NGAL)) receptor is expressed in distal nephron and mediates protein endocytosis. J. Biol. Chem. 2012, 287:159-169.
75. Lee S., Kim J.H., Kim J.H., Seo J.W., Han H.S., Lee W.H., Mori K., Nakao K., Barasch J., Suk K. Lipocalin-2 is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration. J. Biol. Chem. 2011, 286:43855-43870.
76. Lee S., Lee J., Kim S., Park J.Y., Lee W.H., Mori K., Kim S.H., Kim I.K., Suk K. A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol. 2007, 179:3231-3241.
77. Lee S., Lee W.H., Lee M.S., Mori K., Suk K. Regulation by lipocalin-2 of neuronal cell death, migration, and morphology. J. Neurosci. Res. 2012, 90:540-550.
78. Lee S., Park J.Y., Lee W.H., Kim H., Park H.C., Mori K., Suk K. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 2009, 29:234-249.
79. Leheste J.R., Rolinski B., Vorum H., Hilpert J., Nykjaer A., Jacobsen C., Aucouturier P., Moskaug J.O., Otto A., Christensen E.I., Willnow T.E. Megalin knockout mice as an animal model of low molecular weight proteinuria. Am. J. Pathol. 1999, 155:1361-1370.
80. Lesperance F., Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J. Psychosom. Res. 2000, 48:379-391.
81. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 1990, 323:236-241.
82. Li Y.F., Patel K.P. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol. Scand. 2003, 177:17-26.
83. Lindberg S., Jensen J.S., Mogelvang R., Pedersen S.H., Galatius S., Flyvbjerg A., Magnusson N.E. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis. Arterioscler. Thromb. Vasc. Biol. 2014, 34:2135-2142.
84. Lippi G., Montagnana M., Favaloro E.J., Franchini M. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin. Thromb. Hemost. 2009, 35:325-336.
85. Liu H., Luiten P.G., Eisel U.L., Dejongste M.J., Schoemaker R.G. Depression after myocardial infarction: TNF-alpha-induced alterations of the blood-brain barrier and its putative therapeutic implications. Neurosci. Biobehav. Rev. 2013, 37:561-572.
86. Lu L., Chen S.S., Zhang J.Q., Ramires F.J., Sun Y. Activation of nuclear factor-kappa B and its proinflammatory mediator cascade in the infarcted rat heart. Biochem. Biophys. Res. Commun. 2004, 321:879-885.
87. Marques F., Rodrigues A.J., Sousa J.C., Coppola G., Geschwind D.H., Sousa N., Correia-Neves M., Palha J.A. Lipocalin 2 is a choroid plexus acute-phase protein. J. Cereb. Blood Flow Metab. 2008, 28:450-455.
88. Meijer A., Conradi H.J., Bos E.H., Thombs B.D., van Melle J.P., de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen. Hosp. Psychiatry 2011, 33:203-216.
89. Miharada K., Hiroyama T., Sudo K., Danjo I., Nagasawa T., Nakamura Y. Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells. J. Cell. Physiol. 2008, 215:526-537.
90. Mizia-Stec K., Gasior Z., Zahorska-Markiewicz B., Janowska J., Szulc A., Jastrzebska-Maj E., Kobielusz-Gembala I. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron. Artery Dis. 2003, 14:431-438.
91. Moestrup S.K., Verroust P.J. Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia. Annu. Rev. Nutr. 2001, 21:407-428.
92. Mortara A., Bonadies M., Mazzetti S., Fracchioni I., Delfino P., Chioffi M., Bersano C., Specchia G. Neutrophil gelatinase-associated lipocalin predicts worsening of renal function in acute heart failure: methodological and clinical issues. J. Cardiovasc. Med. (Hagerstown) 2013, 14:629-634.
93. Mucha M., Skrzypiec A.E., Schiavon E., Attwood B.K., Kucerova E., Pawlak R. Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18436-18441.
94. Muller N. Immunology of major depression. Neuroimmunomodulation 2014, 21:123-130.
95. Munger M.A., Johnson B., Amber I.J., Callahan K.S., Gilbert E.M. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1996, 77:723-727.
96. Nabi H., Shipley M.J., Vahtera J., Hall M., Korkeila J., Marmot M.G., Kivimaki M., Singh-Manoux A. Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: the Whitehall II cohort study. Heart 2010, 96:1645-1650.
97. Naude P.J., Eisel U.L., Comijs H.C., Groenewold N.A., De Deyn P.P., Bosker F.J., Luiten P.G., den Boer J.A., Oude Voshaar R.C. Neutrophil gelatinase-associated lipocalin: a novel inflammatory marker associated with late-life depression. J. Psychosom. Res. 2013, 75:444-450.
98. Naude P.J., Mommersteeg P.M., Zijlstra W.P., Gouweleeuw L., Kupper N., Eisel U.L., Kop W.J., Schoemaker R.G. Neutrophil gelatinase-associated lipocalin and depression in patients with chronic heart failure. Brain Behav. Immun. 2014, 38:59-65.
99. Naude P.J., Nyakas C., Eiden L.E., Ait-Ali D., van der Heide R., Engelborghs S., Luiten P.G., De Deyn P.P., den Boer J.A., Eisel U.L. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J. 2012, 26:2811-2823.
100. Pan W., Kastin A.J., Zankel T.C., van Kerkhof P., Terasaki T., Bu G. Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier. J. Cell. Sci. 2004, 117:5071-5078.
101. Parikh C.R., Devarajan P. New biomarkers of acute kidney injury. Crit. Care Med. 2008, 36:S159-65.
102. Pasic J., Levy W.C., Sullivan M.D. Cytokines in depression and heart failure. Psychosom. Med. 2003, 65:181-193.
103. Pavon L., Sandoval-Lopez G., Eugenia Hernandez M., Loria F., Estrada I., Perez M., Moreno J., Avila U., Leff P., Anton B., Heinze G. Th2 cytokine response in Major Depressive Disorder patients before treatment. J. Neuroimmunol. 2006, 172:156-165.
104. Penninx B.W., Beekman A.T., Honig A., Deeg D.J., Schoevers R.A., van Eijk J.T., van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch. Gen. Psychiatry 2001, 58:221-227.
105. Pereira V.H., Cerqueira J.J., Palha J.A., Sousa N. Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology. Int. J. Cardiol. 2013, 166:30-37.
106. Pizzi C., Mancini S., Angeloni L., Fontana F., Manzoli L., Costa G.M. Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin. Pharmacol. Ther. 2009, 86:527-532.
107. Pollmacher T., Haack M., Schuld A., Reichenberg A., Yirmiya R. Low levels of circulating inflammatory cytokines-do they affect human brain functions?. Brain Behav. Immun. 2002, 16:525-532.
108. Poole L., Dickens C., Steptoe A. The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J. Psychosom. Res. 2011, 71:61-68.
109. Quan N. In-depth conversation: spectrum and kinetics of neuroimmune afferent pathways. Brain Behav. Immun. 2014, 40:1-8.
110. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
111. Rana I., Stebbing M., Kompa A., Kelly D.J., Krum H., Badoer E. Microglia activation in the hypothalamic PVN following myocardial infarction. Brain Res. 2010, 1326:96-104.
112. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
113. Roest A.M., Carney R.M., Freedland K.E., Martens E.J., Denollet J., de Jonge P. Changes in cognitive versus somatic symptoms of depression and event-free survival following acute myocardial infarction in the Enhancing Recovery In Coronary Heart Disease (ENRICHD) study. J. Affect. Disord. 2013, 149:335-341.
114. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nat. Rev. Neurosci. 2009, 10:423-433.
115. Rubinstein T., Pitashny M., Putterman C. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for Lupus nephritis. Autoimmun. Rev. 2008, 7:229-234.
116. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am. J. Prev. Med. 2002, 23:51-61.
117. Rutledge T., Reis V.A., Linke S.E., Greenberg B.H., Mills P.J. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J. Am. Coll. Cardiol. 2006, 48:1527-1537.
118. Sahinarslan A., Kocaman S.A., Bas D., Akyel A., Ercin U., Zengin O., Timurkaynak T. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease. Coron. Artery Dis. 2011, 22:333-338.
119. Saito A., Pietromonaco S., Loo A.K., Farquhar M.G. Complete cloning and sequencing of rat gp330/"megalin", a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:9725-9729.
120. Schiffer A.A., Pelle A.J., Smith O.R., Widdershoven J.W., Hendriks E.H., Pedersen S.S. Somatic versus cognitive symptoms of depression as predictors of all-cause mortality and health status in chronic heart failure. J. Clin. Psychiatry 2009, 70:1667-1673.
121. Schins A., Hamulyak K., Scharpe S., Lousberg R., Van Melle J., Crijns H., Honig A. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sci. 2004, 76:637-650.
122. Schleifer S.J., Macari-Hinson M.M., Coyle D.A., Slater W.R., Kahn M., Gorlin R., Zucker H.D. The nature and course of depression following myocardial infarction. Arch. Intern. Med. 1989, 149:1785-1789.
123. Schoemaker R.G., Smits J.F. Behavioral changes following chronic myocardial infarction in rats. Physiol. Behav. 1994, 56:585-589.
124. Schroll A., Eller K., Feistritzer C., Nairz M., Sonnweber T., Moser P.A., Rosenkranz A.R., Theurl I., Weiss G. Lipocalin-2 ameliorates granulocyte functionality. Eur. J. Immunol. 2012, 42:3346-3357.
125. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
126. Shang Y.X., Ding W.Q., Qiu H.Y., Zhu F.P., Yan S.Z., Wang X.L. Association of depression with inflammation in hospitalized patients of myocardial infarction. Pak. J. Med. Sci. 2014, 30:692-697.
127. Shashidharamurthy R., Machiah D., Aitken J.D., Putty K., Srinivasan G., Chassaing B., Parkos C.A., Selvaraj P., Vijay-Kumar M. Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice. Arthritis Rheum. 2013, 65:1064-1073.
128. Sherwood A., Blumenthal J.A., Trivedi R., Johnson K.S., O'Connor C.M., Adams K.F., Dupree C.S., Waugh R.A., Bensimhon D.R., Gaulden L., Christenson R.H., Koch G.G., Hinderliter A.L. Relationship of depression to death or hospitalization in patients with heart failure. Arch. Intern. Med. 2007, 167:367-373.
129. Shimizu Y., Suzuki M., Okumura H., Yamada S. Risk factors for onset of depression after heart failure hospitalization. J. Cardiol. 2013.
130. Shrestha K., Borowski A.G., Troughton R.W., Klein A.L., Tang W.H. Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure. Congest Heart Fail. 2012, 18:239-244.
131. Simon N.M., McNamara K., Chow C.W., Maser R.S., Papakostas G.I., Pollack M.H., Nierenberg A.A., Fava M., Wong K.K. A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur. Neuropsychopharmacol. 2008, 18:230-233.
132. Skrzypiec A.E., Shah R.S., Schiavon E., Baker E., Skene N., Pawlak R., Mucha M. Stress-induced lipocalin-2 controls dendritic spine formation and neuronal activity in the amygdala. PLoS One 2013, 8:e61046.
133. Song E., Fan P., Huang B., Deng H.B., Cheung B.M., Feletou M., Vilaine J.P., Villeneuve N., Xu A., Vanhoutte P.M., Wang Y. Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice. J. Am. Heart Assoc. 2014, 3:e000837.
134. Ter Horst G., Nagel J., De Jongste M., Van der Werf Y. Selective blood brain barrier dysfunction after intravenous injections of RTNFα in the rat. Neurochemistry 1997, 141-146. Springer, New York.
135. Thombs B.D., Bass E.B., Ford D.E., Stewart K.J., Tsilidis K.K., Patel U., Fauerbach J.A., Bush D.E., Ziegelstein R.C. Prevalence of depression in survivors of acute myocardial infarction. J. Gen. Intern. Med. 2006, 21:30-38.
136. Thombs B.D., de Jonge P., Coyne J.C., Whooley M.A., Frasure-Smith N., Mitchell A.J., Zuidersma M., Eze-Nliam C., Lima B.B., Smith C.G., Soderlund K., Ziegelstein R.C. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008, 300:2161-2171.
137. Van der Werf Y.D., De Jongste M.J.L., Ter Horst G.J. The immune system mediates blood-brain barrier damage: possible implications for pathophysiology of neuropsychiatric illnesses. Acta Neuropsychiatr. 1995, 7:114-121.
138. van Deursen V.M., Damman K., Voors A.A., van der Wal M.H., Jaarsma T., van Veldhuisen D.J., Hillege H.L. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure. Circ. Heart Fail. 2014, 7:35-42.
139. Van Dijk A., Vermond R.A., Krijnen P.A., Juffermans L.J., Hahn N.E., Makker S.P., Aarden L.A., Hack E., Spreeuwenberg M., van Rossum B.C., Meischl C., Paulus W.J., Van Milligen F.J., Niessen H.W. Intravenous cluster in administration reduces myocardial infarct size in rats. Eur. J. Clin. Invest. 2010, 40:893-902.
140. Whooley M.A., de Jonge P., Vittinghoff E., Otte C., Moos R., Carney R.M., Ali S., Dowray S., Na B., Feldman M.D., Schiller N.B., Browner W.S. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008, 300:2379-2388.
141. Writing Group Members, Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., Ferguson T.B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P.M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M.M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V.L., Rosamond W., Sacco R., Sorlie P., Roger V.L., Thom T., Wasserthiel-Smoller S., Wong N.D., Wylie-Rosett J., American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
142. Xu G., Ahn J., Chang S., Eguchi M., Ogier A., Han S., Park Y., Shim C., Jang Y., Yang B., Xu A., Wang Y., Sweeney G. Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation. J. Biol. Chem. 2012, 287:4808-4817.
143. Yang B., Fan P., Xu A., Lam K.S., Berger T., Mak T.W., Tse H.F., Yue J.W., Song E., Vanhoutte P.M., Sweeney G., Wang Y. Improved functional recovery to I/R injury in hearts from lipocalin-2 deficiency mice: restoration of mitochondrial function and phospholipids remodeling. Am. J. Transl. Res. 2012, 4:60-71.
144. Yndestad A., Landro L., Ueland T., Dahl C.P., Flo T.H., Vinge L.E., Espevik T., Froland S.S., Husberg C., Christensen G., Dickstein K., Kjekshus J., Oie E., Gullestad L., Aukrust P. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur. Heart J. 2009, 30:1229-1236.
145. Zhang J., Wu Y., Zhang Y., Leroith D., Bernlohr D.A., Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol. Endocrinol. 2008, 22:1416-1426.
146. Zhao P., Elks C.M., Stephens J.M. The induction of lipocalin-2 expression in vivo and in vitro. J. Biol. Chem. 2014.
147. Ziegelstein R.C., Fauerbach J.A., Stevens S.S., Romanelli J., Richter D.P., Bush D.E. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch. Intern. Med. 2000, 160:1818-1823.